Sonoma Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The …

Drug Manufacturers - Specialty & Generic
US, Woodstock [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Sonoma Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Sonoma Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Sonoma Pharmaceuticals, Inc..

End of SNOA's Analysis
CIK: 1367083 CUSIP: 83558L204 ISIN: US83558L2043 LEI: - UEI: -
Secondary Listings
SNOA has no secondary listings inside our databases.